In:
International Journal of Cancer, Wiley, Vol. 148, No. 8 ( 2021-04-15), p. 1821-1827
Abstract:
What's new? In vivo studies and small clinical trials have demonstrated that influenza vaccine induces anti‐tumor changes in the immune system, warranting investigation of whether influenza vaccine can be associated with mortality on a large population‐based scale. This Danish registry‐based observational cohort study found that receiving an influenza vaccine within 6 months after surgery for solid cancers had an association with reduced overall‐ and cancer‐specific mortality. As the influenza vaccine is well tolerated among patients at risk, it could potentially represent a patient‐friendly oncological treatment. The findings call for randomized controlled prospective trials further investigating a potential causal relationship.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
